Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · IEX Real-Time Price · USD
0.685
-0.005 (-0.80%)
At close: May 1, 2024, 4:00 PM
0.689
+0.004 (0.66%)
After-hours: May 1, 2024, 5:59 PM EDT
Atara Biotherapeutics Stock Forecast
ATRA's stock price has decreased by -75.64% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for ATRA stock have an average target of 8.37, with a low estimate of 0.50 and a high estimate of 25. The average target predicts an increase of 1,122.79% from the current stock price of 0.68.
Analyst Consensus: Hold
* Price targets were last updated on Apr 1, 2024.
Analyst Ratings
The average analyst rating for ATRA stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $4.8 → $2.3 | Hold | Maintains | $4.8 → $2.3 | +236.01% | Apr 1, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $3 → $0.5 | Strong Sell | Maintains | $3 → $0.5 | -26.95% | Nov 10, 2023 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 9, 2023 |
| Mizuho | Mizuho | Strong Buy → Hold Downgrades $31 → $1 | Strong Buy → Hold | Downgrades | $31 → $1 | +46.09% | Nov 9, 2023 |
Financial Forecast
Revenue This Year
102.48M
from 8.57M
Increased by 1,095.38%
Revenue Next Year
84.72M
from 102.48M
Decreased by -17.33%
EPS This Year
-0.71
from -2.61
EPS Next Year
-0.56
from -0.71
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 188.9M | 134.4M | 71.9M | 120.8M | 157.5M |
| Avg | 102.5M | 84.7M | 69.9M | 117.3M | 153.0M |
| Low | 39.2M | 15.7M | 67.1M | 112.7M | 147.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2,103.2% | 31.1% | -15.1% | 72.8% | 34.3% |
| Avg | 1,095.4% | -17.3% | -17.5% | 67.9% | 30.4% |
| Low | 357.2% | -84.7% | -20.8% | 61.3% | 25.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.42 | -0.05 | -0.63 | -0.58 | -0.42 |
| Avg | -0.71 | -0.56 | -0.62 | -0.56 | -0.41 |
| Low | -0.98 | -1.13 | -0.59 | -0.54 | -0.39 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.